← Back to Search

Integrin Antagonist

nanomicellular cyclosporine 0.09% for Dry Eye Syndrome

Phase 4
Recruiting
Research Sponsored by Toyos Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial will compare the effectiveness of two different eye drops in reducing corneal staining before cataract or LASIK surgery.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in central corneal staining
Secondary outcome measures
change in OSDI questionnaire with additional questions of dysgeusia, blurriness and sensation of burning
change in Schirmers testing
change in corneal topography

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nanomicellular Cyclosporine 0.09 prior to surgeryExperimental Treatment1 Intervention
50 subjects receive nanomicellular cyclosporien 0.09% prior to elective ophthalmic surgery
Group II: Lifitegrast 5.0%Active Control1 Intervention
50 subjects receive liftigrast 5.0% prior to elective ophthalmic surgery

Find a Location

Who is running the clinical trial?

Toyos ClinicLead Sponsor
8 Previous Clinical Trials
160 Total Patients Enrolled
Sun Pharmaceutical Industries LimitedIndustry Sponsor
64 Previous Clinical Trials
13,411 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days
2020. "Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04172961.
All > Xiidra > Restasis
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top